Aditxt, Inc (ADTX) to Acquire Appili Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Assets include the FDA-approved LIKMEZ™, the ATI-1701 tularemia vaccine defense program that has been awarded a USD $14 million non-dilutive award from the DoD, and the ATI-1801 topical.
Patent coverage provides drug market exclusivity through at least 2039
Pre-IND meeting with the FDA granted to discuss ATI-1701’s regulatory, CMC, toxicology, and Phase 1 strategies
.
Pueblo Department of Public Health & Environment issues health alert for summertime krdo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from krdo.com Daily Mail and Mail on Sunday newspapers.